Johnson Wealth Management LLC Invests $1.55 Million in Procter & Gamble Company (The) $PG

Key Points

• Johnson Wealth Management LLC opened a new position in Procter & Gamble during the fourth quarter, buying 10,818 shares worth about $1.55 million. The stake represents 0.8% of the firm’s portfolio and its 20th-largest holding.
• Procter & Gamble posted solid recent results, with EPS of $1.59 beating estimates while revenue came in at $21.24 billion. The company also raised its quarterly dividend to $1.0885 per share, or $4.35 annually, for a yield of about 2.9%.
• Analysts remain broadly constructive, with the stock carrying a Moderate Buy consensus and an average price target of $161.06. Recent headlines also highlighted PG’s defensive appeal and product/brand initiatives, including new Downy and OLAY-related launches.

Johnson Wealth Management LLC purchased a new position in Procter & Gamble Company (The) (NYSE:PG - Free Report) in the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor purchased 10,818 shares of the company's stock, valued at approximately $1,550,000. Procter & Gamble accounts for 0.8% of Johnson Wealth Management LLC's portfolio, making the stock its 20th largest holding.

A number of other institutional investors also recently made changes to their positions in PG. Brighton Jones LLC lifted its stake in shares of Procter & Gamble by 51.5% in the 4th quarter. Brighton Jones LLC now owns 40,068 shares of the company's stock worth $6,717,000 after acquiring an additional 13,617 shares during the period. Taylor Financial Group Inc. lifted its stake in shares of Procter & Gamble by 10.6% in the 1st quarter. Taylor Financial Group Inc. now owns 2,891 shares of the company's stock worth $493,000 after acquiring an additional 277 shares during the period. Sivia Capital Partners LLC lifted its stake in shares of Procter & Gamble by 19.8% in the 2nd quarter. Sivia Capital Partners LLC now owns 6,144 shares of the company's stock worth $979,000 after acquiring an additional 1,016 shares during the period. Auxano Advisors LLC lifted its stake in shares of Procter & Gamble by 10.8% in the 2nd quarter. Auxano Advisors LLC now owns 7,315 shares of the company's stock worth $1,165,000 after acquiring an additional 714 shares during the period. Finally, Schnieders Capital Management LLC. lifted its stake in Procter & Gamble by 2.8% during the second quarter. Schnieders Capital Management LLC. now owns 30,182 shares of the company's stock valued at $4,809,000 after purchasing an additional 809 shares during the last quarter. 65.77% of the stock is owned by institutional investors and hedge funds.

Key Headlines Impacting Procter & Gamble

Here are the key news stories impacting Procter & Gamble this week:

• Positive Sentiment: Jim Cramer praised Procter & Gamble as a stock that helps investors safely own higher-volatility tech names, reinforcing PG’s appeal as a defensive holding during market sell-offs. Jim Cramer Says “The P&Gs and the J&Js in Your Portfolio Allow You to Safely Own the Techs”
• Positive Sentiment: P&G’s Downy brand launched Boutique Botanicals scent beads, expanding its premium home care lineup and potentially supporting growth in a core category. Procter And Gamble Taps Cynthia Rowley For Premium Downy Scent Launch
• Positive Sentiment: Haut.AI’s collaboration with OLAY on virtual companion skincare technology could strengthen P&G’s beauty innovation and improve the consumer experience for a major brand. Haut.AI Collaborates with OLAY on Virtual Companion Technology to Power Clinically Modeled Skincare Simulations
• Neutral Sentiment: P&G presented at the Evercore Consumer & Retail Conference, which may have kept attention on the company but did not include a clear new financial catalyst. The Procter & Gamble Company (PG) Presents at The 6th Annual Evercore Consumer & Retail Conference Transcript
• Neutral Sentiment: Commentary pieces continued to frame PG as a dependable dividend and “market shield” stock, reinforcing its defensive profile rather than signaling a major new operational development. 1 Plain-As-Day Dividend King to Buy and Never Sell That Has Paid a Continuous Dividend Since 1891 How Procter and Gamble Became the Market’s Shield

Procter & Gamble Stock Up 0.5%

PG stock opened at $149.36 on Thursday. Procter & Gamble Company has a 52-week low of $137.62 and a 52-week high of $167.25. The company's 50 day simple moving average is $144.44 and its 200-day simple moving average is $147.70. The company has a debt-to-equity ratio of 0.44, a current ratio of 0.73 and a quick ratio of 0.53. The firm has a market capitalization of $347.80 billion, a P/E ratio of 21.84, a P/E/G ratio of 6.38 and a beta of 0.39.

Procter & Gamble (NYSE:PG - Get Free Report) last released its quarterly earnings results on Friday, April 24th. The company reported $1.59 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.56 by $0.03. Procter & Gamble had a net margin of 19.16% and a return on equity of 32.00%. The business had revenue of $21.24 billion for the quarter, compared to analyst estimates of $21.52 billion. During the same quarter in the previous year, the business earned $1.54 earnings per share. The firm's revenue was up 7.4% compared to the same quarter last year. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. As a group, equities research analysts anticipate that Procter & Gamble Company will post 6.91 EPS for the current year.

Procter & Gamble Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, May 15th. Stockholders of record on Friday, April 24th were issued a dividend of $1.0885 per share. This is an increase from Procter & Gamble's previous quarterly dividend of $1.06. This represents a $4.35 dividend on an annualized basis and a dividend yield of 2.9%. The ex-dividend date was Friday, April 24th. Procter & Gamble's dividend payout ratio (DPR) is presently 63.60%.

Analyst Upgrades and Downgrades

Several analysts recently commented on the stock. Jefferies Financial Group cut their target price on shares of Procter & Gamble from $179.00 to $175.00 and set a "buy" rating for the company in a research note on Monday, April 20th. Raymond James Financial cut their target price on shares of Procter & Gamble from $175.00 to $170.00 and set an "outperform" rating for the company in a research note on Tuesday, April 14th. The Goldman Sachs Group cut their target price on shares of Procter & Gamble from $159.00 to $155.00 and set a "neutral" rating for the company in a research note on Wednesday, April 8th. Evercore set a $162.00 target price on shares of Procter & Gamble in a research note on Monday, April 27th. Finally, Piper Sandler increased their target price on shares of Procter & Gamble from $142.00 to $145.00 and gave the company a "neutral" rating in a research note on Friday, April 24th. Eleven analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company. According to MarketBeat, Procter & Gamble currently has an average rating of "Moderate Buy" and a consensus price target of $161.06.

About Procter & Gamble

Procter & Gamble NYSE: PG is a multinational consumer goods company headquartered in Cincinnati, Ohio. Founded in 1837 by William Procter and James Gamble, P&G has grown into one of the world's largest producers of branded consumer packaged goods. The company focuses on developing, manufacturing and marketing a broad portfolio of household and personal care products sold to consumers and retailers worldwide.

P&G's product offering spans several core business categories, including Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care.

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Procter & Gamble Company (The) (NYSE:PG - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.